Belluscura inks deal to double manufacturing capacity
By HME News Staff
Updated 10:53 AM CDT, Thu March 31, 2022
LONDON – Belluscura has signed a three-year manufacturing agreement for its X-PLO2r portable oxygen concentrator with InnoMax Medical Technology in China. “Manufacturing X-PLO2R products at the national innovation center for medical devices with an affiliate of the world’s leading electronics manufacturing company is transformational,” said Robert Rauker, CEO of Belluscura. “The agreement will more than double our manufacturing capacity and will provide access to the significantly larger Asian market – in China alone there are five times the COPD cases than in the U.S.” InnoMax is a joint venture between MaxNerva Technology Services Limited, which is an affiliate of one of the leading contract electronics manufacturers in the world, and the National Center for the Advanced Medical Devices, which is located in Shenzhen.
Comments